Extrapulmonary manifestations in children diagnosed with M. pneumoniae infection should not be regarded as a disease limited to the respiratory tract and should be considered in children presenting with rash or unexplained multisystem involvement.
Abstract
Background
Extrapulmonary manifestations of Mycoplasma pneumoniae infection affect multiple organ systems in children, but comprehensive data outside hospitalized settings remain limited. We assessed the frequency and clinical characteristics of extrapulmonary manifestations in children with M. pneumoniae infection.
Methods
In this single-center retrospective study, we reviewed records of children younger than 18 years diagnosed with M. pneumoniae infection at Denizli State Hospital between January 2024 and March 2026. Demographic, clinical, laboratory and treatment data were analyzed; patients with co-infection, underlying disease or incomplete data were excluded.
Results
Of 348 children with M. pneumoniae infection, 206 (59%) had extrapulmonary involvement; after exclusions, 144 (41%) with acute infection-related extrapulmonary manifestations were analyzed (median age, 9.4 years; male-to-female ratio, 1.25). Approximately 12% required hospitalization. Dermatologic involvement was the most common finding (34%), followed by gastrointestinal/hepatic (13.2%), renal (8.3%), musculoskeletal (7%), hematologic (6.9%) and neurologic (3.5%) involvement. Dermatologic manifestations were more frequent in children younger than 5 years, whereas renal, musculoskeletal and neurologic involvement predominated in those older than 12 years. Age and C-reactive protein levels were associated with specific manifestation types on univariate analysis, but these associations were not retained on multivariate analysis. All patients recovered without sequelae or death.
Conclusions
Extrapulmonary manifestations occurred in a substantial proportion of children with M. pneumoniae infection and involved multiple organ systems, most commonly the skin. Mycoplasma pneumoniae infection should not be regarded as a disease limited to the respiratory tract and should be considered in children presenting with rash or unexplained multisystem involvement.
Mycoplasma pneumoniae
is a well-established pathogen that affects both the upper and lower respiratory tracts in children and adolescents. It can also affect the skin, mucous membranes, central nervous system, and other tissues. Epidemics occur every 3 to 5 years and by the end of 2023, a resurgence of cases was...
M. Broide, K. Kaidar, Chen Rosenberg Danziger et al.· Infectious Diseases in Clini...· 0 citations
Most reported extrapulmonary manifestations in children with M. pneumoniae appear to be immune-mediated, although direct microbial effects and vascular or prothrombotic mechanisms may contribute in selected cases.
Svjetlana Mikulić· Journal of Pediatric Infecti...· 0 citations
To determine proportional morbidity among the children admitted with pneumonia and study clinical, laboratory, radiological findings, management of MP pneumonia (MPP), among hospitalized community-acquired pneumonia (CAP) cases in a tertiary care setting.
Sri Sounderya Yuvaraja Krishnan, Aishwarya Chidhambaram, N. Gowrishankar et al.· Annals of Child Health· 0 citations
The clinical spectrum, diagnostic challenges, management, and outcomes of adolescent patients diagnosed with MIRM at a tertiary care center are described, with favourable clinical outcomes, with recurrence seen only in 1 patient during follow-up.
Swati Gupta, Diksha Aswal, Shweta Grover· Journal of Skin and Sexually...· 0 citations
Elevated C-reactive protein concentrations and abnormal auscultation may help identify adults with hMPV infection who are more likely to have pneumonia, particularly among hospitalized patients.
T. Saraya, Junki Tashiro, Hajime Furuno et al.· Journal of Clinical Medicine· 0 citations
This retrospective study evaluated seven pediatric patients in whom C. auris was detected in a tertiary pediatric intensive care unit in Türkiye between February 2023 and February 2024 and presented the experience in controlling a suspected healthcare-associated C. auris outbreak and the treatment approaches implemente...
D. N. Penezoğlu, G. Arga, B. H. Inceli et al.· Mycopathologia· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.